AOP Health Presents New Findings Regarding Consistent Hematologic Response of Patients With polycythaemia vera
AOP Health announced new results on ropeginterferon alfa2b BESREMi from its clinical study CONTINUATIONPV in patients with polycythaemia vera PV a rare blood cancer.
Jean Jacques Kiladjian Arpad Illes Christoph Klade Kurt Krejcy Dorota Krochmalczyk Hansc Hasselbalch
Source: businesswireindia.com